Kiniksa shareholders elect all director nominees and approve all 13 proposals at annual meeting

Kiniksa Pharmaceuticals International, plc

All 10 director nominees elected; Stephen R. Biggar received 15.3M against votes, Felix J. Baker 12.3M against.
Say-on-pay (Prop 10) passed with 49.1M for, 550.7K against.
Authority to allot shares up to ~35% of share capital (Prop 11) passed: 41.2M for, 11.2M against.
Disapplication of pre-emption rights (Prop 12) passed: 40.7M for, 11.7M against.
Preference share redemption to create distributable reserves (Prop 13) passed with 52.4M for, 23.2K against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.